type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 10 of 11

TRENDING

EDITORS CHOICE

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

Medika Life -
The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

Mixing Covid Vaccines May Not Be a Great Idea, Research Shows

Medika Life -
Research from, Oxford's Com-Cov study highlights how mixing vaccine brands during follow-up covid vaccinations increases the risk of mild to moderate side effects.

Baby Born With Protective Antibodies After Maternal Covid-19 Vaccination

Dr Jeff Livingston -
No pregnant person's birth plan was to deliver their baby during a global pandemic. The more than 3.7 million individuals who give birth in the United...

Azithromycin

Medika Life -
Azithromycin is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories